Compare NVCR & VET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVCR | VET |
|---|---|---|
| Founded | 2000 | 1994 |
| Country | Switzerland | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2015 | 2004 |
| Metric | NVCR | VET |
|---|---|---|
| Price | $14.70 | $11.95 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $26.86 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 978.6K |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 3.26% |
| EPS Growth | ★ 21.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $655,353,000.00 | N/A |
| Revenue This Year | $10.80 | $22.90 |
| Revenue Next Year | $10.83 | $8.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.28 | N/A |
| 52 Week Low | $9.82 | $7.10 |
| 52 Week High | $21.45 | $14.82 |
| Indicator | NVCR | VET |
|---|---|---|
| Relative Strength Index (RSI) | 37.07 | 49.30 |
| Support Level | $13.12 | $11.88 |
| Resistance Level | $15.19 | $12.22 |
| Average True Range (ATR) | 0.62 | 0.32 |
| MACD | -0.12 | 0.01 |
| Stochastic Oscillator | 29.51 | 74.25 |
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.
Vermilion Energy Inc is an international oil and gas-producing company. The company engages in full-cycle exploration and production programs that focus on the acquisition, exploration, and development of liquids-rich natural gas in Canada and conventional natural gas in Europe while optimizing low-decline oil assets. Its operating segments are: Canada, France, Netherlands, Germany, Ireland, Australia, and CEE, each representing the oil and gas exploration operations at its assets located in these regions. The company mainly derives revenue from the production and sale of petroleum and natural gas. The majority of its revenue is generated from Canada, where the company's operations are mainly focused on the Deep Basin trend in the West Pembina region of Alberta and on the Mica property.